Skip to main content
. 2015 Oct-Dec;6(4):577–580. doi: 10.4103/0976-237X.169843

Figure 4.

Figure 4

(a) Positive immunoreactivity for vimentin. (b) Positive immunoreactivity for CD31. (c) Positive immunoreactivity for CD34. (d) Positive immunoreactivity for KI-67